Webinar
UK Medicines Switch Applications (POM - P – GSL Reclassification)
In this insightful webinar, Chris Englerth, our Director of Global Consulting Services, moderated the session alongside Graham Donaldson – Director, Regulatory Affairs UK and Ireland, Sophie Brand – Senior Manager, Regulatory Affairs, and James King – a leading expert in medicines reclassification, to explore the opportunities, feasibility and hurdles of POM to P and P to GSL switches in the UK.
Key insights
- Why companies choose to switch. The requirements and outline of the process for a medicine reclassification in the UK, and dossier content for each type of application.
- Candidate selection criteria. The benefit-risk approach and considerations for a Scientific Advice Meeting.
- Non-regulatory considerations, naming, and exclusivity post-switch.
Access the recording
Pardot Form
Connect with our team
Our team of leading value experts is dedicated to transforming evidence, policy insights, and market intelligence into effective global market access strategies. Let us help you navigate today’s complex healthcare landscape with confidence. Reach out to discover how we can support your goals.
